Suppr超能文献

一种用于细胞特异性核酸靶向的亲和体的结构预测与验证

Structure prediction and validation of an affibody engineered for cell-specific nucleic acid targeting.

作者信息

Gopal Vijaya, Guruprasad Kunchur

机构信息

Centre for Cellular and Molecular Biology, (Council for Scientific and Industrial Research), Uppal Road, Hyderabad, Andhra Pradesh 500007 India.

出版信息

Syst Synth Biol. 2010 Dec;4(4):293-7. doi: 10.1007/s11693-011-9074-7. Epub 2011 Feb 17.

Abstract

Cell-penetrating peptides comprising cloned epitopes that contribute to membrane transduction, DNA-binding and cell targeting functions are known to facilitate nucleic acid delivery. Using the ITASSER software, we predicted the 3-D structure of a well characterized and efficient transfecting cell-penetrating peptide, namely TAT-Mu and its derivative TAT-Mu-AF protein that harbors a targeting ligand, the HER2-binding affibody. Our model predicts TAT-Mu-AF fusion protein as primarily comprising α-helices. The affibody in TAT-Mu-AF is predicted as a 3-helical domain that is distinct from the TAT-Mu domain. Its positioning in three-dimensional structure is oriented in a manner that possibly favors interactions with receptor and facilitates transport to the target site. The linker region between TAT-Mu and the affibody is also predicted as a helix that is likely to stabilize the overall fold of the TAT-Mu-AF complex. Further, the evaluation of secondary structure of the designed TAT-Mu-AF fusion protein by circular dichroism is in support of our predictions.

摘要

已知包含有助于膜转导、DNA结合和细胞靶向功能的克隆表位的细胞穿透肽可促进核酸递送。我们使用ITASSER软件预测了一种特征明确且高效转染的细胞穿透肽TAT-Mu及其衍生物TAT-Mu-AF蛋白的三维结构,TAT-Mu-AF蛋白含有靶向配体HER2结合亲合体。我们的模型预测TAT-Mu-AF融合蛋白主要由α螺旋组成。TAT-Mu-AF中的亲合体被预测为一个与TAT-Mu结构域不同的三螺旋结构域。其在三维结构中的定位方式可能有利于与受体相互作用并促进向靶位点的转运。TAT-Mu与亲合体之间的连接区也被预测为一个螺旋,可能稳定TAT-Mu-AF复合物的整体折叠。此外,通过圆二色性对设计的TAT-Mu-AF融合蛋白二级结构的评估支持了我们的预测。

相似文献

1
Structure prediction and validation of an affibody engineered for cell-specific nucleic acid targeting.
Syst Synth Biol. 2010 Dec;4(4):293-7. doi: 10.1007/s11693-011-9074-7. Epub 2011 Feb 17.
2
Targeting human epidermal growth factor receptor 2 by a cell-penetrating peptide-affibody bioconjugate.
Biomaterials. 2012 Mar;33(8):2570-82. doi: 10.1016/j.biomaterials.2011.12.003. Epub 2011 Dec 20.
6
Designed multi-domain protein as a carrier of nucleic acids into cells.
J Control Release. 2009 Jan 19;133(2):154-60. doi: 10.1016/j.jconrel.2008.09.090. Epub 2008 Oct 11.
7
Development of elastin-like polypeptide for targeted specific gene delivery in vivo.
J Nanobiotechnology. 2020 Jan 17;18(1):15. doi: 10.1186/s12951-020-0574-z.
8
Study of uptake of cell penetrating peptides and their cargoes in permeabilized wheat immature embryos.
FEBS J. 2008 May;275(10):2403-14. doi: 10.1111/j.1742-4658.2008.06384.x. Epub 2008 Apr 7.
9
Evaluation of backbone-cyclized HER2-binding 2-helix affibody molecule for in vivo molecular imaging.
Nucl Med Biol. 2013 Apr;40(3):378-86. doi: 10.1016/j.nucmedbio.2012.12.009. Epub 2013 Jan 26.

引用本文的文献

1
A novel B- and helper T-cell epitopes-based prophylactic vaccine against .
Bioimpacts. 2018;8(1):39-52. doi: 10.15171/bi.2018.06. Epub 2017 Dec 20.
2
Differential Evolutionary Selection and Natural Evolvability Observed in ALT Proteins of Human Filarial Parasites.
PLoS One. 2016 Feb 18;11(2):e0148611. doi: 10.1371/journal.pone.0148611. eCollection 2016.
3
Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies.
Drug Des Devel Ther. 2013 Jul 18;7:571-83. doi: 10.2147/DDDT.S46393. Print 2013.

本文引用的文献

1
Plasmid DNA delivery into MDA-MB-453 cells mediated by recombinant Her-NLS fusion protein.
Int J Nanomedicine. 2010 Oct 5;5:725-33. doi: 10.2147/IJN.S13040.
2
siRNA delivery using peptide transduction domains.
Trends Pharmacol Sci. 2009 Jul;30(7):341-5. doi: 10.1016/j.tips.2009.04.009. Epub 2009 Jun 21.
3
4
Biosynthesis and characterization of a novel genetically engineered polymer for targeted gene transfer to cancer cells.
J Control Release. 2009 Sep 15;138(3):188-96. doi: 10.1016/j.jconrel.2009.04.017. Epub 2009 Apr 18.
5
Designed multi-domain protein as a carrier of nucleic acids into cells.
J Control Release. 2009 Jan 19;133(2):154-60. doi: 10.1016/j.jconrel.2008.09.090. Epub 2008 Oct 11.
6
Alternative binding proteins: affibody binding proteins developed from a small three-helix bundle scaffold.
FEBS J. 2008 Jun;275(11):2668-76. doi: 10.1111/j.1742-4658.2008.06438.x. Epub 2008 Apr 24.
7
I-TASSER server for protein 3D structure prediction.
BMC Bioinformatics. 2008 Jan 23;9:40. doi: 10.1186/1471-2105-9-40.
8
TAT transduction: the molecular mechanism and therapeutic prospects.
Trends Mol Med. 2007 Oct;13(10):443-8. doi: 10.1016/j.molmed.2007.08.002.
9
Template-based modeling and free modeling by I-TASSER in CASP7.
Proteins. 2007;69 Suppl 8:108-17. doi: 10.1002/prot.21702.
10
Ab initio modeling of small proteins by iterative TASSER simulations.
BMC Biol. 2007 May 8;5:17. doi: 10.1186/1741-7007-5-17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验